Package 70771-1658-3

{"route": ["ORAL"], "spl_id": "432dc54b-f28b-48c9-b417-2fbae070f41b", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["1494769", "1812419", "1812421", "1812425", "1812427"], "spl_set_id": ["57b5d67b-b29b-4c18-a53d-51d5374f3be3"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Zydus Lifesciences Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1658-3)", "package_ndc": "70771-1658-3", "marketing_start_date": "20230117"}, {"sample": false, "description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1658-9)", "package_ndc": "70771-1658-9", "marketing_start_date": "20230117"}], "brand_name": "Topiramate", "product_id": "70771-1658_432dc54b-f28b-48c9-b417-2fbae070f41b", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70771-1658", "generic_name": "Topiramate", "labeler_name": "Zydus Lifesciences Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "100 mg/1"}], "application_number": "ANDA208949", "marketing_category": "ANDA", "marketing_start_date": "20230117", "listing_expiration_date": "20261231"}